Herbert A. Fritsche
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer Genomics and Diagnostics 16
- Breast Cancer Treatment Studies 13
- Oncology 60
- HER2/EGFR in Cancer Research 19
- Cancer Cells and Metastasis 19
- Co-authors
- Daniel F. HayesRobert C. BastRobert MennelPeter M. RavdinMark R. SomerfieldMassimo CristofanilliLarry NortonSheila E. Taube
- Journals
- Clinical Chemistry (13 papers)Journal of Clinical Oncology (12 papers)The Journal of Urology (11 papers)Cancer (11 papers)Urology (10 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Herbert A. Fritsche
163 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 3.9k
- Oncology 5.8k
- Pulmonary and Respiratory Medicine 2.8k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Pathology and Forensic Medicine 916
Countries citing papers authored by Herbert A. Fritsche
This map shows the geographic impact of Herbert A. Fritsche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert A. Fritsche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert A. Fritsche more than expected).
Fields of papers citing papers by Herbert A. Fritsche
This network shows the impact of papers produced by Herbert A. Fritsche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert A. Fritsche. The network helps show where Herbert A. Fritsche may publish in the future.
Co-authors
The 25 scholars most cited alongside Herbert A. Fritsche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 15 | |
| 4 | 2020 | 10 | |
| 5 | 2014 | 17 | |
| 6 | Comparison of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaTest breast cancer for detection and biological characterization | 2008 | 2 |
| 7 | 2008 | 66 | |
| 8 | American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer Hit paper breakdown → | 2007 | 1670 |
| 9 | 2006 | 26 | |
| 10 | Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer - A multi-center validation study of the CellSearch™ system. | 2006 | 13 |
| 11 | 2006 | 39 | |
| 12 | 2005 | 115 | |
| 13 | 2003 | 253 | |
| 14 | Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. | 2002 | 36 |
| 15 | 2002 | 42 | |
| 16 | 1999 | 132 | |
| 17 | Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers Hit paper breakdown → | 1996 | 553 |
| 18 | 1990 | 101 | |
| 19 | c-erbB-2 amplification in node-negative human breast cancer. | 1989 | 105 |
| 20 | 1985 | 1 |
About Herbert A. Fritsche
Herbert A. Fritsche is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 163 papers that have together received 11.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (25 papers), HER2/EGFR in Cancer Research (19 papers), Cancer Cells and Metastasis (19 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Ovarian cancer diagnosis and treatment (16 papers), Cancer Genomics and Diagnostics (16 papers) and Breast Cancer Treatment Studies (13 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (5.8k citations), Pulmonary and Respiratory Medicine (2.8k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Pathology and Forensic Medicine (916 citations). Herbert A. Fritsche has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Daniel F. Hayes, Robert C. Bast, Robert Mennel, Peter M. Ravdin, Mark R. Somerfield, Massimo Cristofanilli, Larry Norton, Sheila E. Taube, Gabriel N. Hortobágyi and Lyndsay N. Harris. Their work appears in journals such as Clinical Chemistry, Journal of Clinical Oncology, The Journal of Urology, Cancer and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.